SCHEMBL10082262

SCHEMBL10082262

C[N+](C)=c1ccc2c(-c3ccccc3C(=O)O)c3ccc(B(O)O)cc3oc-2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ THRB P10828 2/20 0.48
▸ RECQL P46063 2/20 0.48
▸ BLM P54132 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ FTO Q9C0B1 2/20 0.45
▸ ABCB1 P08183 1/20 0.43
▸ USP2 O75604 5/20 0.42
▸ ATM Q13315 2/20 0.42
▸ CFTR P13569 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ GOPC Q9HD26 1/20 0.42
▸ P2RY6 Q15077 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ POLB P06746 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10082261 0.86 USP2 (0.56) MEN1KMT2ATHRBRECQLBLM
SCHEMBL12582030 0.86 KDM4E (0.49) MEN1KMT2ATHRBRECQLBLM
Tetramethylrhodamine SCHEMBL2054818 0.83 MEN1 (0.71) MEN1KMT2ATHRBRECQLBLM
SCHEMBL15355554 0.83 MEN1 (0.48) MEN1KMT2ATHRBRECQLBLM
SCHEMBL10082264 0.83 SOS1 (0.50) MEN1KMT2ATHRBRECQLBLM
SCHEMBL15289851 0.79 MEN1 (0.44) MEN1KMT2ATHRBRECQLBLM
SCHEMBL13045851 0.77 ABCB1 (0.48) MEN1KMT2ATHRBRECQLBLM
SCHEMBL12763951 0.76 POLB (0.50) MEN1KMT2ATHRBRECQLBLM
SCHEMBL19494774 0.76 USP2 (0.53) MEN1KMT2ATHRBRECQLBLM
SCHEMBL10082276 0.76 MEN1 (0.53) MEN1KMT2ATHRBRECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140127137-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS Cercacor Laboratories, Inc (US) 2014-05-08 — — US disclosed
US-8466286-B2 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors CERCACOR LABORATORIES, INC. (US) 2013-06-18 — — US disclosed
US-8466286-B2 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors CERCACOR LABORATORIES, INC. (US) 2013-06-18 — — US disclosed
US-20120052018-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS MASIMO LABORATORIES, INC. (US) 2012-03-01 — — US disclosed
US-20120052018-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS MASIMO LABORATORIES, INC. (US) 2012-03-01 — — US disclosed
US-8029765-B2 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors MASIMO LABORATORIES, INC. (US) 2011-10-04 — — US disclosed
US-8008088-B2 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors MASIMO LABORATORIES, INC. (US) 2011-08-30 — — US disclosed
US-8008088-B2 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors MASIMO LABORATORIES, INC. (US) 2011-08-30 — — US disclosed
US-20090004108-A1 Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors MASIMO LABORATORIES, INC. (US) 2009-01-01 — — US disclosed
US-20090004108-A1 Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors MASIMO LABORATORIES, INC. (US) 2009-01-01 — — US disclosed
US-20070110672-A1 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors CERCACOR LABORATORIES, INC. 2007-05-17 — — US disclosed
US-20070110672-A1 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors CERCACOR LABORATORIES, INC. 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140127137-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS GCKR, SYMPK, SUCNR1 MEN1 606/4885KMT2A 3286/4885THRB 3639/4885
US-20070110672-A1 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors GCKR, SYMPK, SUCNR1 MEN1 606/4885KMT2A 3286/4885THRB 3639/4885
US-20120052018-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS GCKR, SYMPK, SUCNR1 MEN1 606/4885KMT2A 3286/4885THRB 3639/4885
US-20090004108-A1 Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors GCKR, SYMPK, SUCNR1 MEN1 606/4885KMT2A 3286/4885THRB 3639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback